L-arginine Effects on Chronic Hypertension in Pregnancy

Effects of Oral L-arginine on Chronic Hypertension in Pregnancy

The purpose of this study is to evaluate the effects of oral L-arginine administration on pregnant women at second trimester of gestation with chronic hypertension, respect with placebo.

Inclusion Criteria:

• Pregnant women between 18-20 weeks of gestation with chronic hypertension

Exclusion Criteria:

• Other maternal or fetal systemic disease